Compare LACTOSE INDIA with KOPRAN. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs KOPRAN. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA KOPRAN. LACTOSE INDIA/
KOPRAN.
 
P/E (TTM) x -126.6 27.1 - View Chart
P/BV x 2.0 6.0 32.6% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 LACTOSE INDIA   KOPRAN.
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
KOPRAN.
Mar-21
LACTOSE INDIA/
KOPRAN.
5-Yr Chart
Click to enlarge
High Rs42146 28.5%   
Low Rs1622 73.9%   
Sales per share (Unadj.) Rs30.6113.7 26.9%  
Earnings per share (Unadj.) Rs-2.214.2 -15.2%  
Cash flow per share (Unadj.) Rs1.616.6 9.9%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Avg Dividend yield %01.8 0.0%  
Book value per share (Unadj.) Rs30.156.7 53.2%  
Shares outstanding (eoy) m11.4443.25 26.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.90.7 127.8%   
Avg P/E ratio x-13.35.9 -226.0%  
P/CF ratio (eoy) x17.65.1 347.0%  
Price / Book Value ratio x1.01.5 64.6%  
Dividend payout %010.5 0.0%   
Avg Mkt Cap Rs m3303,634 9.1%   
No. of employees `000NANA-   
Total wages/salary Rs m106372 28.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3504,918 7.1%  
Other income Rs m3182 1.7%   
Total revenues Rs m3535,100 6.9%   
Gross profit Rs m62816 7.6%  
Depreciation Rs m44102 42.8%   
Interest Rs m5462 87.3%   
Profit before tax Rs m-33833 -3.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-8217 -3.6%   
Profit after tax Rs m-25616 -4.0%  
Gross profit margin %17.816.6 107.2%  
Effective tax rate %24.226.1 93.0%   
Net profit margin %-7.112.5 -56.6%  
BALANCE SHEET DATA
Current assets Rs m1972,769 7.1%   
Current liabilities Rs m1161,607 7.2%   
Net working cap to sales %23.123.6 97.7%  
Current ratio x1.71.7 98.3%  
Inventory Days Days595 1,082.7%  
Debtors Days Days671891 75.3%  
Net fixed assets Rs m6861,624 42.3%   
Share capital Rs m114433 26.4%   
"Free" reserves Rs m2302,018 11.4%   
Net worth Rs m3452,450 14.1%   
Long term debt Rs m393212 185.1%   
Total assets Rs m8834,394 20.1%  
Interest coverage x0.414.4 2.8%   
Debt to equity ratio x1.10.1 1,315.3%  
Sales to assets ratio x0.41.1 35.4%   
Return on assets %3.415.4 21.8%  
Return on equity %-7.225.1 -28.6%  
Return on capital %3.033.6 8.8%  
Exports to sales %040.5 0.0%   
Imports to sales %7.46.5 113.4%   
Exports (fob) Rs mNA1,990 0.0%   
Imports (cif) Rs m26321 8.1%   
Fx inflow Rs m251,990 1.2%   
Fx outflow Rs m27374 7.1%   
Net fx Rs m-21,617 -0.1%   
CASH FLOW
From Operations Rs m22600 3.6%  
From Investments Rs m-62-244 25.3%  
From Financial Activity Rs m45-346 -13.1%  
Net Cashflow Rs m510 52.6%  

Share Holding

Indian Promoters % 49.1 43.8 112.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.7 0.9 74.7%  
FIIs % 0.0 0.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.9 56.2 90.5%  
Shareholders   15,737 37,822 41.6%  
Pledged promoter(s) holding % 47.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Hero MotoCorp's Investment in Ather Energy, UltraTech Cement Quarterly Results, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday. Benchmark indices ended with marginal gains in a choppy session supported by auto stocks.

Related Views on News

KOPRAN. 2020-21 Annual Report Analysis (Annual Result Update)

Nov 9, 2021 | Updated on Nov 9, 2021

Here's an analysis of the annual report of KOPRAN. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of KOPRAN.. Also includes updates on the valuation of KOPRAN..

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Jan 17, 2022 (Close)

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA 5-YR ANALYSIS

COMPARE LACTOSE INDIA WITH

MARKET STATS